Most reports on FRA-1 in breast cancer dissemination rely on analyses of lung metastases formed by intravenously injected fully mesenchymal TNBC lines (e.g., MDA-MB-231) subjected to FOSL1 silencing. The gene discussed is FOSL1; the disease is breast carcinoma.